- Article metrics
- Last updated: Tue, 23 Apr 2024 23:17:07 Z
NKP-1339, a first-in-class anticancer drug showing mild side effects and activity in patients suffering from advanced refractory cancer
Access & Citations
-
- 2479
- Article Accesses
-
- 0
- Web of Science
-
- 15
- CrossRef
Citation counts are provided from Web of Science and CrossRef. The counts may vary by service, and are reliant on the availability of their data. Counts will update daily once available.